Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model.
Laco GS, Collins JR, Luke BT, Kroth H, Sayer JM, Jerina DM, Pommier Y, Biochemistry, 2002 Feb 5 - link